Bobby Gaspar - 01 Apr 2022 Form 4 Insider Report for Orchard Therapeutics plc

Role
Chief Executive Officer, Director
Signature
/s/ Bobby Gaspar
Issuer symbol
N/A
Transactions as of
01 Apr 2022
Net transactions value
+$11,085
Form type
4
Filing time
05 Apr 2022, 16:15:29 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORTX Ordinary Shares Purchase $11,085 +15,000 +4.3% $0.7390 366,158 01 Apr 2022 Direct F1, F2
holding ORTX Ordinary Shares 2,000 01 Apr 2022 By Reporting Person's Child F1
holding ORTX Ordinary Shares 2,000 01 Apr 2022 By Reporting Person's Child F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.722 to $0.75. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.